Selective endothelin receptor antagonist

This page covers all Selective endothelin receptor antagonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Endothelin receptor (ETA/ETB).

Targets

Endothelin receptor (ETA/ETB)

Phase 3 pipeline (1)

• EFI/ACT-385781A · Actelion · Cardiovascular
  EFI/ACT-385781A is a selective endothelin receptor antagonist that blocks endothelin-1 signaling to reduce pulmonary vascular resistance and improve hemodynamics.

Patent intelligence

• selective endothelin receptor antagonist patent landscape — aggregated cliff calendar, attackable patents, originator estates